BSE filing, NSE: KILITCH. Summary written from the filing by ALFA Finder's alert engine.
Kilitch Drugs(I) Ltd: key numbers
- Share price
- ₹201.32
- Market cap
- ₹703.9 Cr
- Revenue (annual)
- ₹235.5 Cr
- Net profit (annual)
- ₹30.17 Cr
- P/E (TTM)
- 23.4×Sector 45.9×
- Promoter holding
- 63.77%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kilitch Drugs(I) Ltd
All →Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs' EGM notice seeks shareholder approval for selling its Ethiopian material subsidiary and converting subsidiary debt into equity. It also proposes two independent director appointments.
Kilitch Drugs(I) Merger & Restructuring Worth ₹131.6 Cr
Kilitch Drugs will divest its entire Ethiopian subsidiary stake to HarmeeCare for US$14 million (~₹131.6 Crore). Proceeds will fund debt repayment and Pen plant expansion.
- Value
- ₹131.6 Cr
Kilitch Drugs(I) Merger & Restructuring Worth ₹120.8 Cr
Kilitch Drugs will divest its 100% stake in subsidiary Kilitch Estro Biotech PLC for USD 12.855 million (approx. ₹120.84 Crore).
- Value
- ₹120.8 Cr
- From
- HarmeeCare Pharmaceuticals
Kilitch Drugs(I) Management Change
Kilitch Drugs' Non-Executive Independent Director Mr. Venkita Subramanian Rajan resigned effective 21 Oct 2026. He also stepped down from the Audit, NCR, and SRC Committees citing personal commitments.
Kilitch Drugs(I) Other Announcement
Kilitch Drugs (India) Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs (India) held its 34th Annual General Meeting on August 27, 2026, transacting four business resolutions including financial statement approval and director re-appointment.
Other board meeting date announcements
All →Rexnord Electronics and Controls Board Meeting Date
Rexnord Electronics & Controls informed BSE of a board meeting on 5 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The trading window has been closed since 1 October 2026.
Anna Infrastructures Board Meeting Date
Anna Infrastructures Ltd has intimated BSE of a board meeting on 12 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The notice also confirms the trading window stays closed until 48 hours after the meeting.
Garuda Construction and Engineering Board Meeting Date
Garuda Construction and Engineering will hold a board meeting on 04-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The filing is a prior intimation of the future meeting.
Exicom Tele-Systems Board Meeting Date
Exicom Tele-Systems will hold a board meeting on November 4, 2026 to consider Q2 and half-year unaudited results. The trading window will reopen on November 7, 2026.
Vidya Wires Board Meeting Date
Vidya Wires will hold a board meeting on November 4, 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after the results are made public.
Abirami Financial Services (India) Board Meeting Date
Abirami Financial Services board meets 11 November 2026 to consider unaudited September 2026 quarterly results. Prior intimation; trading window closed from 1 October 2026.